Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes

• Main Authors: Hadi Rajabi (Author), Mahdi Ahmadi (Author), Somayeh Aslani (Author), Shirin Saberianpour (Author), Reza Rahbarghazi (Author)
• Format: Book
• Published: Tabriz University of Medical Sciences, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Type 2 diabetes mellitus (T2DM) is a chronic metabolic abnormality leading to microvascular and macrovascular complications. Non-insulin Incretin mimic synthetic peptide exendin-4 was introduced as an anti-diabetic drug which helped diabetic patients with triggering insulin secretion; further resear...